This study, recently published in medRxiv, represents a significant step forward in how we classify and understand Hypertrophic Cardiomyopathy (HCM)—a leading cause of sudden cardiac death. By moving away from subjective visual assessments and toward a data-driven, 3D machine-learning approach, the researchers have mapped the complex relationship between a patient's genetic makeup and the physical structure of their heart.
TL;DR
Researchers developed a "3D taxonomy" of heart shapes in HCM patients using machine learning on cardiac MRI data. This map reveals that heart remodeling exists on a continuum where specific structural patterns are strongly linked to high-risk genetic variants and significantly higher mortality rates.
What Problem Does This Paper Address?
Hypertrophic cardiomyopathy (HCM) is notoriously "heterogeneous," meaning it looks and behaves differently in every patient. Traditionally, doctors have classified HCM based on subjective descriptions of heart wall thickening (e.g., "sigmoid" or "reverse curve").
However, these labels often fail to capture the underlying biology. Some patients have clear "sarcomeric" genetic mutations (the classic cause), while others do not, despite having similar-looking hearts. There is currently no systematic framework that links the 3D shape of the heart (phenotype) with genetic risk (genotype) and clinical outcomes. This gap makes it difficult to personalize treatment or accurately predict which patients are at the highest risk for heart failure or sudden death.
Methods
The authors employed a sophisticated multi-step pipeline:
- 3D Cardiac Modeling: Using deep learning, they automatically segmented Cardiac Magnetic Resonance (CMR) images to create high-resolution 3D models of the left ventricle (LV) for over 17,000 individuals.
- Unsupervised Learning: They used a technique called DDRTree (discriminative dimensionality reduction via learning a tree) to project these complex 3D shapes into a 2D "phenotypic tree." This allowed them to see how different heart shapes transition into one another.
- Genomic Integration: They stratified patients by rare variants (pathogenic/likely pathogenic, VUS, or negative) and calculated Polygenic Risk Scores (PGS) to account for common genetic modifiers.
- Survival Analysis: They projected mortality data onto the tree to see if specific "branches" were deadlier than others.
Datasets
- Discovery Cohort: 436 HCM patients from the NIHR Royal Brompton Hospital Cardiovascular Biobank (UK).
- Validation Cohort: 60 HCM patients from Singapore to test the model's generalizability across different ancestries.
- Reference Population: 16,691 genotype-negative individuals from the UK Biobank to establish "normal" heart geometry.
Key Insights and Ideas
- The Genotype-Phenotype Paradox: Surprisingly, patients with the most dangerous genetic variants (SARC-P/LP) actually had lower overall heart mass than those without mutations. However, their thickening was much more localized to the basal septum (the top part of the wall dividing the heart chambers).
- Four Main "Branches" of Disease: The unsupervised model identified four distinct structural trajectories:
- Non-sarcomeric: Thickening at the mid-to-apex, often linked to hypertension.
- Obstructive: Diffuse thickening associated with blood flow blockage (LVOTO).
- Isolated Basal: A milder, potentially age-related form.
- Familial Sarcomeric: Milder overall thickening but highly enriched for high-risk genetic mutations.
- Continuous vs. Categorical: The study argues that HCM isn't a set of discrete boxes but a continuum. The "tree" captures the transition from undifferentiated heart shapes in the center to highly specific disease patterns at the tips of the branches.
Key Results
- Mortality Risk: Carriers of pathogenic variants (SARC-P/LP) had a 2.66x higher risk of death compared to genotype-negative patients, with a significantly shorter median lifespan (67 vs. 76 years).
- Genetic Enrichment: Branch 4 was the most "genetic," with an odds ratio of 2.18 for carrying a pathogenic variant.
- Generalizability: The model proved robust when applied to the Singaporean cohort, achieving a "trustworthiness" score of 0.86–0.88, suggesting the 3D patterns of HCM transcend ethnic boundaries.
- Polygenic Influence: Even in patients without a single "smoking gun" mutation, common genetic variations (measured via PGS) significantly influenced the specific shape and severity of heart remodeling.
Limitations and Future Work
The authors acknowledge that their primary biobank may be biased toward patients stable enough to undergo MRI, potentially missing the most acute or severe cases. Additionally, while the Singaporean cohort provided some ancestral diversity, the vast majority of the training data was from individuals of European descent.
Future work aims to integrate "multi-omic" data—like proteomics and transcriptomics—directly into the 3D map. The ultimate goal is a clinical tool where a patient’s MRI can be "mapped" onto the tree to immediately provide a personalized risk profile and genetic probability.
Summary updated